Erika Carmel-Tech (XTAE:ERKA) ROCE %: -68.89% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ERKA Erika Carmel-Tech Ltd XTAE:ERKA
32 GF Score
Price ₪0.52
GF Value ₪0.55
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Erika Carmel-Tech ROCE %?

Erika Carmel-Tech XTAE:ERKA 32 ROCE % is -68.89% as of Dec. 2025. GuruFocus rates XTAE:ERKA with a GF Score™ of 32/100 and a GF Value™ of ₪0.55 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Erika Carmel-Tech's annualized ROCE % for the quarter that ended in Dec. 2025 was -68.89%.

Erika Carmel-Tech  (XTAE:ERKA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Erika Carmel-Tech ROCE % Related Terms

Erika Carmel-Tech ROCE % Historical Data

* Premium members only.

The historical data trend for Erika Carmel-Tech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Erika Carmel-Tech ROCE % Chart

Erika Carmel-Tech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -33.16 -39.74 -48.59 -45.35 -39.06

Erika Carmel-Tech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -65.47 3.12 -94.95 -13.22 -68.89
XTAE:ERKA
32GF Score
Erika Carmel-Tech Ltd XTAE:ERKA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Erika Carmel-Tech ROCE % Calculation

Erika Carmel-Tech's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-5.788/( ( (34.748 - 16.864) + (29.157 - 17.406) )/ 2 )
=-5.788/( (17.884+11.751)/ 2 )
=-5.788/14.8175
=-39.06 %

Erika Carmel-Tech's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-9.372/( ( (31.513 - 16.056) + (29.157 - 17.406) )/ 2 )
=-9.372/( ( 15.457 + 11.751 )/ 2 )
=-9.372/13.604
=-68.89 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -68.89% mean?
Erika Carmel-Tech (XTAE:ERKA) has a ROCE % of -68.89% as of Dec. 2025.
Is Erika Carmel-Tech's ROCE % too high?
Erika Carmel-Tech's current ROCE % is -68.89%. Overall, Erika Carmel-Tech has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's ROCE % compare to ABT and SYK?
Erika Carmel-Tech's ROCE % of -68.89% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.22, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Erika Carmel-Tech's current ROCE % is -68.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Fairly Valued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.52 — trading 6.4% below its estimated fair value. The current ROCE % is -68.89%. Erika Carmel-Tech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current ROCE % is -68.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?

Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued. The current stock price of ₪0.52 is trading 6.4% below its estimated GF Value™ of ₪0.55. GuruFocus considers Erika Carmel-Tech to be Fairly Valued.

Key valuation signals for XTAE:ERKA:

  • ROCE %: -68.89%
  • GF Value™: ₪0.55 vs. price of ₪0.52 (6.4% below fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Erika Carmel-Tech Business Description

Address Nahum Hat 5, Entrance 2, Haifa, ISR, 3508504
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
32GF Score

Get the complete analysis for XTAE:ERKA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.52
Price
₪0.55
GF Value